Skip to main content

Advertisement

SpringerLink
Log in

Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL)

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

Our purpose was to evaluate the ability of re-combinant human granulocyte colony-stimulating factor (r-metHuG-CSF) as an adjunct to induction chemo-therapy of acute lymphoblastic leukemia (ALL) to ameliorate chemotherapy-induced neutropenia and thus allow patients to receive full doses of chemotherapy on time. Sixteen consecutive patients with adult ALL (13 de novo, three relapsed) were treated with induction chemo-therapy according to the BMFT protocol and received in addition r-metHuG-CSF (200μg/m2/day). Patients who were treated with the same induction chemotherapy but without G-CSF between 1982 and 1990 served as controls. Fifteen of the 16 patients achieved complete hematological remission. One patient died because of fungal septicemia. Compared with historical controls, G-CSF-treated patients had a significantly faster neutrophil recovery in phase I, resulting in neutrophil counts > 1000/μl at day 17 vs day 26 (in median) in controls. In phase II, the onset of severe leukocytopenia (< 1500/μl) was significantly (p = 0.01) delayed and the degree of leukocytopenia less pronounced (mean nadir 3300/μl) in G-CSF-treated patients compared with controls (1880/μl). The number of days of febrile neutropenia was not different in phase I. In phase II it was lower in study patients (0 vs 1.1 days), but the difference did not reach statistical significance (p = 0.09). Full doses of chemo-therapy could be given on time to 11/13 (85%) G-CSF pa-tients but to only 7/30 (23%) controls. These data indicate that (a) G-CSF can be given along with chemotherapy in induction treatment of ALL without compromising efficacy; (b) the duration of neutropenia in phase I is markedly shortened and the degree of leukocytopenia in phase II ameliorated; (c) these beneficial effects allow patients to receive full doses of chemotherapy on time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Benett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (FAB Cooperative Group 1981) The morphological classification of acute lymphoblastic leukemia: concordance among observers and clinical correlations. Br J Haematol 47: 553–561

    Google Scholar 

  2. Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328–340

    Google Scholar 

  3. Brandt SJ, Peters WP, Atwater SK, Kurtzberg J, Borowitz MJ, Jones RB, Shpall EJ, Bast RC, Gilbert CJ, Oette DH (1988) Effect of granulocyte colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 318: 869–876

    Google Scholar 

  4. Bronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, Testa NG, Dexter TM (1987) Phase-I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 56: 809–813

    Google Scholar 

  5. Budman DR, Wood W, Henderson IC, Korzun AH, Cooper R, Younger J, Hart RD, Moore A, Ellerton J, Norton L, Ferree C, Colangelo A, McIntyre OR (1992) Initial findings of CALGB 8541: a dose and dose-intensity trial of cyclophosphamide (c), doxorubicin (a), and 5-fluoruracil (f) as adjuvant treatment of stage-II, node+, female breast cancer. Am Soc Clin Oncol 11: 51 (abstr 29)

    Google Scholar 

  6. Champlin R, Gale RP (1989) Acute lymphoblastic leukemia: recent advances in biology and therapy. Blood 73: 2051–2066

    Google Scholar 

  7. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G, Smith R, Gradishar W, Yahanda A, Vincent M, Stewart M, Glaspy J (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325: 164–170

    Google Scholar 

  8. Foon KA, Todd RF (1986) Immunologic classification of leu-kemia and lymphoma. Blood 68: 1–31

    Google Scholar 

  9. Frei E, Canellos GP (1980) Dose: a critical factor in cancer chemotherapy. Am J Med 69: 585–593

    Google Scholar 

  10. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MAS, Clarkson B, Oettgen HF, Alton K, Welte K, Souza L (1988) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium. N Engl J Med 318: 1414–1422

    Google Scholar 

  11. Hoelzer D, Thiel E, Löffler H, Bodenstein H, Plaumann L, Büchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Müller U, Wendt FC, Sodomann H, Rühl H, Herrmann RF, Kaboth W, Dietzfelbinger H, Pralle H, Lunscken Ch, Hellriegel KP, Spors S, Nowrousian RM, Fischer J, Fülle H, Mitrou PS, Pfreundschuh M, Görg Ch, Emmerich B, Queisser W, Meyer P, Labedzki L, Essers U, König H, Mainzer K, Herrmann R, Messerer D, Zwinger T (1984) Intensified therapy in acute lymphoblastic leukemia in adults. Blood 64: 38–47

    Google Scholar 

  12. Hoelzer D, Thiel E, Löffler H, Büchner T, Ganser A, Heil G, Koch P, Freund H, Diedrich H, Ruhl H, Maschmeyer G, Lipp T, Nowrousian RM, Burkert M, Gerecke D, Pralle H, Müller U, Lunscken C, Fülle H, Ho AD, Kuchler R, Busch FW, Schneider W, Görg C, Emmerich B, Braumann D, Vaupel HA, von Paleske A, Bartels H, Neiss A, Messerer D (1988) Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71: 123–131

    Google Scholar 

  13. Hornung RL, Longo DL (1992) Hematopoietic stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapy. Blood 80: 77–83

    Google Scholar 

  14. Kantarjian HM, Estey EH, O'Brien S, Anaissie E, Beran M, Rios MB, Keating MJ, Gutterman J (1992) Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphoblastic leukemia. Blood 79: 876–881

    Google Scholar 

  15. Kantarjian HM, Walters RS, Keating MJ, Smith TL, O'Brien S, Estey EH, Huh YO, Spinolo J, Dicke K, Barlogie B, Mc-Credie KB, Freireich EJ (1990) Results of the vincristine, doxorubicin and dexamethasone regimen in adults with standard-and high-risk acute lymphocytic leukemia. J Clin Oncol 8: 994–1004

    Google Scholar 

  16. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481

    Google Scholar 

  17. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick FP (1988) Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemicspecific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 85: 5698–5702

    Google Scholar 

  18. Miyamura K, Tanimoto M, Morishima Y, Horibe K, Yamamuto K, Akatsuka M, Kodera Y, Kojima S, Matsuyama K, Hirabayashi N, Yazaki M, Imai K, Onozawa Y, Kanamaru A, Mizutani S, Saito H (1992) Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marrow transplantation. Blood 79: 1366–1470

    Google Scholar 

  19. Nicola NA, Begely CG, Metcalf D (1985) Identification of the human analogue of a regulator that induces differentiation in murine Ieukaemic cells. Nature 314: 625–628

    Google Scholar 

  20. Ohno R, Tomonaga M, Kobayashi T, Kanamaru A, Shirakawa S, Masaoka T, Omine M, Oh H, Nomura T, Sakai Y, Hirano M, Yokomaku S, Nakayama S, Yoshida Y, Miura AB, Morishima Y, Dohy H, Niho Y, Hamajima N, Takaku F (1990) Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med 323: 871–877

    Google Scholar 

  21. Pinkel D, Hernandez K, Borella L, Holton C, Aur R, Samoy G, Pratt C (1971) Drug dosage and remission duration in child-hood lymphocytic leukemia. Cancer 27: 247–256

    Google Scholar 

  22. Riehm H, Gadner H, Henze G (1990) Results and significance of six randomized trials in four consecutive ALL-BFM studies. In: Büchner T, Schellong G, Hiddemann W, Ritter J (eds) Haematology and blood transfusion, acute leukemias. II. Springer, Berlin Heidelberg New York, pp 439–449

    Google Scholar 

  23. Sheridan WP, Morstyn G, Wolf M, Dodds A, Lusk J, Maher D, Layton JE, Green MD, Souza L, Fox RM (1989) Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2: 891–895

    Google Scholar 

  24. Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503–517

    Google Scholar 

  25. Taylor KM, Jagannath S, Spitzer G, Spinolo JA, Tucker SL, Fogel B, Cabanillas F, Hagemeister FB, Souza LM (1989) Recombinant human granulocyte-colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J Clin Oncol 7: 1791–1799

    Google Scholar 

  26. Yoshida T, Nakamura S, Ohtake S, Okafuji K, Kobayashi K, Kondo K, Kanno M, Matano S, Matusda T, Kanai M (1990) Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma. Cancer 66: 1904–1909

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, First Medical Department, University of Vienna, Währinger Gürtel 18-20, A-1090, Vienna, Austria

    R. Scherrer, K. Geissler, P. A. Kyrle, H. Gisslinger, U. Jäger, P. Bettelheim, K. Laczika, G. Locker, C. Scholten, C. Sillaber, I. Schwarzinger, F. Thalhammer & K. Lechner

Authors
  1. R. Scherrer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Geissler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. A. Kyrle
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Gisslinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. U. Jäger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Bettelheim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. Laczika
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Locker
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C. Scholten
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C. Sillaber
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. I. Schwarzinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. F. Thalhammer
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. K. Lechner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scherrer, R., Geissler, K., Kyrle, P.A. et al. Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL). Ann Hematol 66, 283–289 (1993). https://doi.org/10.1007/BF01695970

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01695970

Key words

Search

Navigation